60 DEGREES PHARMACEUTICALS, INC. (Nasdaq:SXTP)
Health Care/Life Sciences • Pharmaceuticals
CIK 1946563
Company
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.
Address
1025 Connecticut Avenue NW
Suite 1000
Washington, District of Columbia 20036
1025 Connecticut Avenue NW
Suite 1000
Washington, District of Columbia 20036
Employees
3
3
Stock Info
Close
$1.6200
$1.6200
Day Range
1.5700 - 1.7000
1.5700 - 1.7000
52 Week Range
1.5400 - 35.9940
1.5400 - 35.9940
Average volume
471.43K
471.43K
Short Interest
23.79K (02/14/25)
23.79K (02/14/25)
% of Float Shorted
2.02%
2.02%
Market Cap
$2.39M
$2.39M
Revenue
$253.57K
$253.57K
Net Income
-$3.7M
-$3.7M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director Geoffrey S. Dow |
Director Xu Cheryl |
Independent Director Stephen Toovey |
Independent Director Paul Field |
Independent Director Charles W. Allen |
SEC filings
Date | Form | Event |
---|---|---|
18 Dec, 2024 | 4 | |
9 Dec, 2024 | 4 | |
21 Nov, 2024 | 4 | |
14 Nov, 2024 | 10-Q | |
14 Nov, 2024 | SC 13G | |
13 Nov, 2024 | SC 13G/A | |
6 Nov, 2024 | 8-K | |
15 Oct, 2024 | DEF 14A | |
8 Oct, 2024 | 8-K | |
2 Oct, 2024 | PRE 14A | |
30 Sep, 2024 | EFFECT | |
26 Sep, 2024 | CORRESP | |
24 Sep, 2024 | UPLOAD | |
19 Sep, 2024 | S-3 | |
11 Sep, 2024 | 4 | |
6 Sep, 2024 | 8-K | |
28 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
14 Aug, 2024 | 8-K | |
12 Aug, 2024 | 8-K | |
2 Aug, 2024 | 424B5 | |
26 Jul, 2024 | 8-K | |
26 Jul, 2024 | 424B5 | |
24 Jul, 2024 | 424B5 | |
22 Jul, 2024 | 424B5 | |
18 Jul, 2024 | EFFECT | |
16 Jul, 2024 | 8-K | |
16 Jul, 2024 | CORRESP | |
15 Jul, 2024 | UPLOAD | |
12 Jul, 2024 | S-3 | |
9 Jul, 2024 | 8-K | |
27 Jun, 2024 | 8-K | |
12 Jun, 2024 | 8-K | |
30 May, 2024 | DEF 14A | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
15 May, 2024 | 10-Q | |
7 May, 2024 | SC 13G/A | |
3 May, 2024 | PRE 14A | |
2 May, 2024 | 8-K | |
3 Apr, 2024 | 4 | |
1 Apr, 2024 | 10-K | |
15 Mar, 2024 | 8-K | |
28 Feb, 2024 | 8-K | |
20 Feb, 2024 | 8-K | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 8-K | |
2 Feb, 2024 | 4 | |
31 Jan, 2024 | 424B4 | |
29 Jan, 2024 | EFFECT | |
26 Jan, 2024 | CORRESP | |
26 Jan, 2024 | CORRESP | |
26 Jan, 2024 | CORRESP | |
22 Jan, 2024 | CORRESP | |
22 Jan, 2024 | S-1 | |
22 Jan, 2024 | 8-K | |
22 Jan, 2024 | CORRESP | |
18 Jan, 2024 | UPLOAD | |
16 Jan, 2024 | 8-K | |
12 Jan, 2024 | DRS | |
18 Dec, 2023 | 3 | |
18 Dec, 2023 | SC 13G | |
20 Nov, 2023 | 10-Q | |
15 Nov, 2023 | NT 10-Q | |
3 Nov, 2023 | 8-K | |
12 Oct, 2023 | 8-K | |
18 Sep, 2023 | 8-K | |
25 Aug, 2023 | 10-Q | |
17 Jul, 2023 | 8-K | |
13 Jul, 2023 | 424B4 | IPO completed |
12 Jul, 2023 | 4 | |
12 Jul, 2023 | 4 | |
12 Jul, 2023 | CERT | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | SEC STAFF | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | EFFECT | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
11 Jul, 2023 | 3 | |
7 Jul, 2023 | CORRESP | |
7 Jul, 2023 | CORRESP | |
27 Jun, 2023 | 8-A12B/A | |
27 Jun, 2023 | CORRESP | |
27 Jun, 2023 | CORRESP | |
27 Jun, 2023 | CORRESP | |
22 Jun, 2023 | CORRESP | |
16 Jun, 2023 | CORRESP | |
16 Jun, 2023 | CORRESP | |
14 Jun, 2023 | 8-A12B | |
14 Jun, 2023 | 8-A12B/A | |
14 Jun, 2023 | CORRESP | |
12 Jun, 2023 | CORRESP | |
12 Jun, 2023 | CORRESP | |
8 Jun, 2023 | S-1/A | |
8 Jun, 2023 | CORRESP | |
6 Jun, 2023 | UPLOAD | |
1 Jun, 2023 | S-1/A | |
1 Jun, 2023 | CORRESP | |
26 May, 2023 | UPLOAD | |
24 May, 2023 | D | |
19 May, 2023 | S-1/A | |
19 May, 2023 | CORRESP | |
8 May, 2023 | UPLOAD | |
28 Apr, 2023 | S-1/A | |
28 Apr, 2023 | CORRESP | |
14 Apr, 2023 | UPLOAD | |
14 Apr, 2023 | SEC STAFF | |
3 Apr, 2023 | S-1/A | |
3 Apr, 2023 | CORRESP | |
8 Feb, 2023 | UPLOAD | |
31 Jan, 2023 | S-1 | |
6 Jan, 2023 | UPLOAD | |
23 Dec, 2022 | DRSLTR | |
23 Dec, 2022 | DRS/A | |
16 Dec, 2022 | UPLOAD | |
5 Dec, 2022 | DRS/A | |
5 Dec, 2022 | DRSLTR | |
14 Nov, 2022 | UPLOAD | |
18 Oct, 2022 | DRS |
Last update:2025-03-06 12:24:44.406728
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.